Azamian Bobak R. 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Mar 19, 2026
Research Summary
AI-generated summary of this filing
Tarsus (TARS) CEO Bobak Azamian Sells Shares
What Happened
Bobak R. Azamian, President & CEO and Board Chair of Tarsus Pharmaceuticals (TARS), reported three open‑market sales totaling 34,603 shares between March 17–19, 2026. The sales were: 10,972 shares @ $69.42 on 2026-03-17 ($761,676); 11,667 shares @ $68.71 on 2026-03-18 ($801,640); and 11,964 shares @ $67.00 on 2026-03-19 ($801,588). Total gross proceeds were approximately $2,364,904. These were sales (not purchases) and, per the filing, were routine sell‑to‑cover transactions to satisfy tax withholding tied to RSU vesting—not discretionary stock sales.
Key Details
- Dates & prices:
- 2026-03-17: 10,972 shares @ $69.42 — $761,676
- 2026-03-18: 11,667 shares @ $68.71 — $801,640
- 2026-03-19: 11,964 shares @ $67.00 — $801,588
- Total shares sold: 34,603; total proceeds: ~$2.36M.
- Shares owned after transaction: not specified in the filing.
- Footnotes:
- F1: Sales were mandated sell‑to‑cover to satisfy tax withholding on vested RSUs (not discretionary trades).
- F2: Reporting person is trustee of the Bobak Azamian Living Trust (est. Apr 16, 2018) and has voting/dispositive power over these shares.
- Filing timeliness: Report filed 2026-03-19 for transactions commencing 2026-03-17; the filing does not indicate lateness.
Context
Sell‑to‑cover transactions are common when restricted stock units vest and employers require tax withholdings to be satisfied by selling a portion of the shares. Because these sales were done to cover taxes (per the filing), they generally do not signal the same management sentiment as voluntary, discretionary sales.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-03-17$69.42/sh−10,972$761,676→ 57,052 total - Sale
Common Stock
[F1]2026-03-18$68.71/sh−11,667$801,640→ 45,385 total - Sale
Common Stock
[F1]2026-03-19$67.00/sh−11,964$801,588→ 33,421 total
- 857,991(indirect: By Trust)
Common Stock
[F2]
Footnotes (2)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F2]The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.